Literature DB >> 23794065

C1galt1-deficient mice exhibit thrombocytopenia due to abnormal terminal differentiation of megakaryocytes.

Takashi Kudo1, Takashi Sato, Kozue Hagiwara, Yukinori Kozuma, Takashi Yamaguchi, Yuzuru Ikehara, Michito Hamada, Ken Matsumoto, Masatsugu Ema, Soichiro Murata, Nobuhiro Ohkohchi, Hisashi Narimatsu, Satoru Takahashi.   

Abstract

C1galt1 is essential for synthesis of the core 1 structure of mucin-type O-glycans. To clarify the physiological role of O-glycans in adult hematopoiesis, we exploited the interferon-inducible Mx1-Cre transgene to conditionally ablate the C1galt(flox) allele (Mx1-C1). Mx1-C1 mice exhibit severe thrombocytopenia, giant platelets, and prolonged bleeding times. Both the number and DNA ploidy of megakaryocytes in Mx1-C1 bone marrow were similar to those in wild-type (WT) mice. However, there were few proplatelets in Mx1-C1 primary megakaryocytes. Conversely, bone marrow transplanted from Mx1-C1 to WT and splenectomized Mx1-C1 mice gave rise to observations similar to those described above. The expression of GPIbα messenger RNA was unchanged in Mx1-C1 bone marrow, whereas flow cytometric and western blot analyses using megakaryocytes and platelets revealed that the expression of GPIbα protein was significantly reduced in Mx1-C1 mice. Moreover, circulating Mx1-C1 platelets exhibited an increase in the number of microtubule coils, despite normal levels of α- and β-tubulin. Our observations suggest that O-glycan is required for terminal megakaryocyte differentiation and platelet production and that the decrease in GPIbα in cells lacking O-glycan might be caused by increased proteolysis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23794065     DOI: 10.1182/blood-2012-12-471102

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Multifaceted role of glycosylation in transfusion medicine, platelets, and red blood cells.

Authors:  Melissa M Lee-Sundlov; Sean R Stowell; Karin M Hoffmeister
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

2.  Sialylation on O-glycans protects platelets from clearance by liver Kupffer cells.

Authors:  Yun Li; Jianxin Fu; Yun Ling; Tadayuki Yago; J Michael McDaniel; Jianhua Song; Xia Bai; Yuji Kondo; Yannan Qin; Christopher Hoover; Samuel McGee; Bojing Shao; Zhenghui Liu; Roberto Sonon; Parastoo Azadi; Jamey D Marth; Rodger P McEver; Changgeng Ruan; Lijun Xia
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

3.  Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.

Authors:  Junwei Zeng; Rongjuan Mi; Yingchun Wang; Yujing Li; Li Lin; Bing Yao; Lina Song; Irma van Die; Arlene B Chapman; Richard D Cummings; Peng Jin; Tongzhong Ju
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

4.  Glucuronylated core 1 glycans are required for precise localization of neuromuscular junctions and normal formation of basement membranes on Drosophila muscles.

Authors:  Kazuyoshi Itoh; Yoshihiro Akimoto; Shu Kondo; Tomomi Ichimiya; Kazuhiro Aoki; Michael Tiemeyer; Shoko Nishihara
Journal:  Dev Biol       Date:  2018-02-27       Impact factor: 3.582

5.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

Review 6.  Clinical impact of glycans in platelet and megakaryocyte biology.

Authors:  Hervé Falet; Leonardo Rivadeneyra; Karin M Hoffmeister
Journal:  Blood       Date:  2022-06-02       Impact factor: 25.476

7.  Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.

Authors:  Nanyan Zhang; Siying Lin; Weiguo Cui; Peter J Newman
Journal:  Blood Adv       Date:  2022-07-12

8.  C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.

Authors:  Ji-Shiang Hung; John Huang; Yo-Chuen Lin; Miao-Juei Huang; Po-Huang Lee; Hong-Shiee Lai; Jin-Tung Liang; Min-Chuan Huang
Journal:  Oncotarget       Date:  2014-04-30

Review 9.  C1GALT1 in health and disease.

Authors:  Xiaojie Sun; Mengru Zhan; Xun Sun; Wanqi Liu; Xiangwei Meng
Journal:  Oncol Lett       Date:  2021-06-06       Impact factor: 2.967

10.  Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway.

Authors:  Chih-Hsing Chou; Miao-Juei Huang; Chi-Hau Chen; Ming-Kwang Shyu; John Huang; Ji-Shiang Hung; Chiun-Sheng Huang; Min-Chuan Huang
Journal:  Oncotarget       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.